We may receive commissions for affiliate links included in this article. This is a sponsored post. Future Sharks makes no warranties about the statements, facts and/or claims made on this article. These are the opinions of the author. Read our advertising and contributor disclosure here.
The biotech startup Pneumeric has developed an innovative device that will help save lives as it drastically improves the ability of emergency personnel to treat critical conditions in the field.
The groundbreaking Capnospot gives emergency providers treating a trauma patient the ability to analyze life-or-death results visually, eliminating guesswork, reducing the possibility of human error— and preventing deaths. The potential for the Capnospot to improve outcomes for the military is promising as well.
Invented by Dr. John Aho and used to relieve air pressure that a collapsed lung places on veins leading into the heart, the Capnospot provides visual detection for needle decompression, elevating the standard of care with a clear, binary “yes” or “no” color shift that instantly detects the “gush of air” escaping from a patient’s chest wall.
“People are trying to figure out the gotcha—and there is no gotcha,” Dr. Aho said. “There just isn’t anything that does this for treatment of this condition.”
Pneumeric has raised a million dollars to build on its more than four years of research and development, with plans to bring the product to market—and ultimately every ambulance and emergency room in the United States. Following successful tests on animals and humans, and boasting remarkable pre-clinical and clinical results, Pneumeric is gearing up to submit documentation required for clearance from the FDA. As all of this unfolds, Pneumeric stands on the precipice of altering the trajectory of health care for the injured as we know it.
Investors can learn more about Pneumeric by clicking here.
The Pneumeric and Capnospot stories begin with the pneumothorax, a collapsed lung caused by air leaking into the space between the lung and chest wall. That trapped air causes a tension pneumothorax—the buildup of air pressure that compresses blood vessels carrying blood back to the heart. Within minutes, the patient spirals into cardiac arrest and, sadly, too often, their preventable death follows the trauma caused by the tension pneumothorax.
To treat this condition, emergency medical providers working against the clock are trained to insert a needle and listen for a “gush of air,” an indication they have prevented a tension pneumothorax. A successful diagnosis tool under ideal conditions, this “Gold Standard” of detection can become an exercise in guesswork in the midst of noise and confusion at a trauma scene; onboard a helicopter mid-flight; in the lights and sirens of an ambulance ride; an emergency room; or on the battlefield.
The groundbreaking Capnospot lets emergency providers see their results visually, objectively, and immediately. Guesswork is eliminated and preventable deaths in the field can be eliminated.
“With Capnospot, paramedics can provide essential medical care without having to wonder—or assume—that their methods have worked,” Dr. Aho said. “We remove doubt and replace it with clear, objective data.”
To learn more, visit www.pneumeric-medical.com.